ArticleCureus2025

Comparative Effectiveness of Sodium-Glucose Co-transporter 2 Inhibitors and Thiazolidinediones in Reducing Adverse Cardiovascular Events in Type 2 Diabetes.

Arshad Ali et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.